The SCL gene (also known as TAL-1) encodes a basic helix ± loop ± helix transcription factor that is essential for the development of all haematopoietic lineages, and ectopic expression of which results in T cell leukaemia. SCL is expressed in normal pluripotent haematopoietic stem cells and its expression is maintained during dierentiation along erythroid, mast and megakaryocytic lineages, but is extinguished following commitment to other cell types. The mechanisms responsible for this pattern of expression are poorly understood, but are likely to illuminate the molecular basis for stem cell development and lineage commitment. We have identi®ed multiple lineage-restricted DNase I hypersensitive sites in a 45 kb region spanning the murine SCL locus. Committed erythroid cells and CD34 positive primitive myeloid cells exhibited both shared and unique DNase I hypersensitive sites whereas none were found in T cells. The function of each hypersensitive site was studied using both transient and stable reporter assays in erythroid, primitive myeloid and T cells. Multiple positive and negative regulatory elements were characterised and found to display lineage-speci®city, promoter-speci®city and/or chromatin-dependence. These results represent the ®rst description of key components of a complex network of regulatory elements controlling SCL expression during haematopoiesis.
Introduction
The mechanisms whereby a pluripotent stem cell generates multiple distinct dierentiated cell types remain almost completely obscure. Haematopoiesis provides a powerful paradigm for probing this process. Several lines of evidence demonstrate a central role for transcription factors and it is therefore particularly important to understand what controls the pattern of transcription factor expression during haematopoiesis ± what regulates the regulators? In order to address this question we have elected to study the transciptional regulation of the SCL gene (also known as TAL-1) which encodes a basic helix ± loop ± helix transcription factor, is expressed in pluripotent haematopoietic stem cells and functions as a pivotal regulator of haematopoiesis.
SCL was originally discovered as a result of its activation by chromosome rearrangements in T cell acute lymphoblastic leukaemia (T-ALL) (Begley et al., 1989; Chen et al., 1990; Finger et al., 1989) . SCL expression is activated in these tumours by several mechanisms including chromosome translocations and, more commonly, interstitial deletions which place the SCL gene under the control of the SIL gene promoter (Aplan et al., 1990; Bernard et al., 1990; Brown et al., 1990) . The SCL gene is also expressed in a substantial proportion of T-ALL in the absence of any overt rearrangement, and evidence for both cis and transacting mechanisms has been presented (Bash et al., 1995) . The SCL protein is phosphorylated on serine, contains an N-terminal transactivation domain (Cheng et al., 1993; Goldfarb et al., 1992; Sanchez-Garcia and Rabbitts, 1994 ) and binds to a speci®c E-box as a heterodimer with class A bHLH proteins (Hsu et al., 1994) . More recently, SCL has also been shown to bind to LMO-2, a LIM domain protein which does not appear to bind DNA itself (Valge-Archer et al., 1994; Wadman et al., 1994) . Interestingly, the LMO-2 and SCL null phenotypes are similar and LMO-2 is also a T cell oncogene (Boehm et al., 1991; Royer-Pokora et al., 1991; Warren et al., 1994) .
Mice lacking SCL protein die by embryonic day 10 and exhibit a complete absence of all haematopoietic cells (Porcher et al., 1996; Robb et al., 1995 Robb et al., , 1996 Shivdasani et al., 1995) . Target genes for SCL have not yet been identi®ed, but previous antisense experiments have suggested that SCL may perform distinct functions in dierent haematopoietic cell types. Introduction of antisense constructs into a multipotent cell line resulted in reduced proliferation and selfrenewal (Green et al., 1991a) whereas analogous experiments inhibited dierentiation of a committed erythroid cell line (Aplan et al., 1992) . In addition, SCL has been implicated in the prevention of apoptosis in leukaemic T cells .
SCL is expressed in haematopoietic cells, endothelial cells and in brain (Green et al., 1992; Hwang et al., 1993; Kallianpur et al., 1994; Pulford et al., 1995; . Within the haematopoietic system SCL is expressed in committed erythroid, mast and megakaryocytic cells as well as in IL-3 dependent cell lines (Green et al., 1991b , Kallianpur et al., 1994 Mouthon et al., 1993; Pulford et al., 1995; . Growth factor induced erythroid dierentiation of a multipotent progenitor cell line was accompanied by up-regulation of SCL mRNA, whereas induced granulocyte/monocyte dierentiation resulted in extinction of SCL expression (Cross et al., 1994) . Indeed, down-regulation of SCL expression not only accompanies, but may actually be required for normal myeloid dierentiation, since over-expression of exogenous SCL impaired macrophage dierentiation of M1 cells (Tanigawa et al., 1993) .
This pattern of SCL expression raises several important questions. Firstly, are the same regulatory elements responsible for expression in stem cells and in committed erythroid, mast and megakaryocytic cells? GATA-1 regulates the SCL promoter in erythroid cells (Aplan et al., 1992; Bockamp et al., 1995; and is also expressed at high levels in mast and megakaryocytic cells. GATA-2 recognises a subset of GATA-1 binding sites and is expressed at high levels in multipotent progenitors. The lineage-restricted pattern of SCL expression could therefore re¯ect the presence of one or more regulatory elements responsive to both GATA-1 and GATA-2. Secondly, what drives SCL expression in haematopoietic stem cells? SCL appears to be downstream of GATA genes in committed haematopoietic lineages yet SCL null mice exhibit a more complete absence of haematopoiesis than is found in mice null for GATA-1 or GATA-2 Pevny et al., 1991; Robb et al., 1995; Shivdasani et al., 1995; Tsai et al., 1994) . Thirdly, what is the basis for the down-regulation of SCL expression following commitment to non-expressing lineages? Does this merely re¯ect absence of GATA-1 and/or GATA-2, or is SCL subject to silencing? Since ectopic SCL expression in T cells is tumorigenic, SCL down-regulation during haematopoiesis is likely to be subject to stringent regulation.
In order to investigate these issues we have previously isolated the murine SCL gene (Begley et al., 1994) . Promoter 1a and promoter 1b exhibited lineage-restricted activity in transient reporter assays (Bockamp et al., 1995 (Bockamp et al., , 1997 but stable transfection experiments demonstrated that both promoters required additional sequences to permit their expression following integration in chromatin (Bockamp et al., 1997) . We have now characterized multiple distant regulatory elements that modulate SCL transcription in three dierent haematopoietic cell types: committed erythroid cells, primitive myeloid cells positive for the stem cell antigen CD34 and T cells.
Results
Distinct patterns of lineage-restricted DNase I hypersensitive sites are present in committed erythroid and CD34 positive primitive myeloid cells
To identify regulatory elements important for SCL expression we have mapped DNase I hypersensitive sites in a region of 45 kb encompassing the murine SCL gene. We chose to study two very dierent SCLexpressing haematopoietic cell types: murine erythroleukaemia cells (F4N) which correspond to committed erythroid precursors between the CFU-E and BFU-E stages of dierentiation (Dube et al., 1975) and primitive myeloid cells (M1) positive for the stem cell antigen CD34 (May and Enver, 1995) . M1 cells can be induced to dierentiate into monocytes and so we reasoned that their analysis may provide clues not only to the regulation of SCL in primitive CD34 positive cells, but perhaps also to the mechanisms responsible for SCL down-regulation following commitment to the monocyte lineage. In addition we have anlaysed a T cell line (BW5147) which does not express SCL.
The strategy adopted to map the DNase I hypersensitive sites is shown in Figure 1a . Figure 1b shows DNase I hypersensitive sites upstream of the SCL gene. Probe p1 (Figure 1a ) was hybridized to a Southern blot of DNase I treated DNA digested with ApaI. In addition to the germline fragment of approximately 23 kb (closed arrowhead), one additional band was observed in F4N cells (710HS) and 3 additional bands in M1 cells (710HS, 74.5HS, 73HS), whereas no DNase I hypersensitive sites were detected in the T cell line BW5147. DNase I hypersensitive site nomenclature refers to the position of the hypersensitive site relative to the beginning of exon 1a.
DNase I hypersensitive sites downstream of the SCL gene are shown in Figure 1c . DNase I treated DNA was digested with KpnI and hybridized with probe p2 (Figure 1a ). In addition to the 10 kb germline band (closed arrowhead), two bands of approximately 3 and 4 kb were evident in F4N cells (denoted +17HS and +18HS) . No hypersensitive sites downstream of the SCL gene were detected in M1 or in BW5147.
To study DNase I hypersensitive sites within the body of the SCL gene, DNase I treated DNA was digested with either KpnI (Figure 1d ) or EcoRI ( Figure  1e ). The pattern of hypersensitive sites in F4N cells was best demonstrated using a KpnI digest followed by hybridisation with probe p4. In addition to the germline band of 20 kb, bands of approximately 12, 10 and 6 kb were observed (Figure 1d ). The 12 kb band corresponds to the promoter region, the 10 kb band corresponds to a hypersensitive site upstream of exon 3 (+3HS) and the 6 kb band corresponds to a hypersensitive site at the beginning of exon 4 (+7HS). In analagous Southern blots of M1 and BW5147 DNA, the +7HS but not the +3HS was evident in M1 cells and no hypersensitive sites were detected in BW5147 cells (data not shown). The +7HS could also be detected in M1 and F4N cells using an EcoRI digest and hybridization with probe p3 (Figure 1e and data not shown).
Our experiments therefore demonstrated three hypersensitive sites (+3HS, +17HS, +18HS) to be present in erythroid cells but not in CD34 positive myeloid cells or in T cells. To con®rm the generality of these results we studied a second erythroid cell line generated in a completely dierent way. The F4N cell line used above was derived from a murine erythroleukaemia generated by neonatal infection with the Friend murine leukaemia virus complex (Dube et al., 1975) . We therefore chose to study the J2E cell line which was derived by in vitro infection of murine foetal liver cells with a replication incompetent retrovirus containing myc and raf (Klinken et al., 1988) . J2E cells are growth factor independent and undergo terminal erythroid dierentiation in response to erythropoietin. The pattern of DNase I hypersensitive sites associated with the SCL gene was identical in F4N and J2E cells (data not shown). The DNase I hypersensitive sites associated with the SCL gene are summarised in the top part of Figure 2 . Erythroid and CD34 positive primitive myeloid cells exhibited both shared and unique hypersensitive sites, whereas no hypersensitive sites were found in T cells. These data therefore suggested that distinct combinations of regulatory elements might control SCL expression in dierent haematopoietic cell types.
Multiple lineage-restricted regulatory elements modulate SCL transcription
The function of the putative SCL regulatory elements was assessed using transient luciferase reporter assays. Additional genomic DNA fragments containing the 710HS, +17HS and +18HS were isolated since these were not contained in the phage contig previously described (Begley et al., 1994) . Luciferase reporter constructs were generated in pGL-2 basic and were introduced into F4N, M1 and BW5147 cells.
In F4N cells the core promoter 1b (+0.2E1b) was silent whereas the core promoter 1a (70.2E1a) was modestly active (Figure 3) . A construct containing both promoters with the luciferase gene fused into exon 3 (70.2E3), and which therefore contained the +3HS, was approximately fourfold more active. A very dierent pattern was obtained in M1 cells. Core promoter 1a was inactive, core promoter 1b was strongly active and the inclusion of sequences between exon 1b and exon 3, which contained the +3HS, had no eect. In T cells all three constructs produced low levels of luciferase activity relative to F4N or M1 cells. These results are consistent with the +3HS acting as an enhancer in erythroid but not in primitive myeloid cells. The data could also re¯ect a lineage-speci®c eect on RNA processing and/or stability resulting from the inclusion of introns in the 70.2E3 construct. This seems unlikely, particularly because the parental pGL-2 basic vector already includes an intron.
Distant regulatory elements may in¯uence the pattern of promoter activity seen in dierent cell types. Moreover, each distant regulatory element may act on promoter 1a or promoter 1b or both. Since our aim was to generate a functional assay for distant regulatory elements, it was important to include both promoters in subsequent constructs. The complex alternative splicing pattern associated with the 5' untranslated exons of the murine SCL gene results in exon 3 being the ®rst exon that is shared between transcripts originating at promoters 1a and 1b. It was therefore decided to study the eect of the other hypersensitive sites on the activity of 70.2E3 since this construct contains both SCL promoters together with a physiological splice acceptor at the beginning of exon 3.
The strategy that was adopted is summarised in the lower part of Figure 2 . DNA fragments containing the 710HS, +7HS, and +17/18HS were subcloned downstream of the luciferase gene in 70.2E3. The 73HS and 74.5HS were tested by including 7 kb of sequence upstream of exon 1a (77.0E3). The eect of all these hypersensitive sites on the activity of 70.2E3 in transient reporter assays is shown in Figure 4 . In F4N cells the 710HS, 73/4.5HS and +7HS all resulted in approximately twofold enhancements. The most pronounced eect was seen with the +17/18HS which resulted in a sixfold increase over the already considerable activity of 70.2E3 and a 240-fold increase relative to pGL-2basic. In M1 cells a very dierent pattern was obtained. Inclusion of the 73/4.5HS (construct 77.0E3) produced a twofold increase in activity relative to 70.2E3 alone, whereas the 710HS, +7HS and +17/18HS had no detectable eect. In BW5147 cells, which do not express endogenous SCL mRNA, all of the constructs produced only low levels of activity. Taken together these data show that the 710HS, +7HS and +17/18HS functioned as enhancers in F4N but not M1 cells, whereas the 73/ 4.5HS functioned as an enhancer in both F4N and M1 cells.
Identi®cation of chromatin-dependent silencers and enhancers
It has become increasingly clear that chromatin structure places important constraints on the functional activity of transcriptional regulatory elements (Ernst and Smale, 1995; Felsen®eld, 1992; Lewin, 1994) . It was therefore important to assess the activity of the various SCL regulatory elements following integration into chromatin. The same series of reporter constructs used for the transient transfection assays were introduced into F4N, M1 and BW5147 cells and pools of stably transfected cells were derived. Analysis of pools rather than individual clones was performed to minimise position eects. Pools of cells carrying pGL-2 basic were used as negative controls and pools carrying pA3RSVluc (in which luciferase is driven by the RSV LTR) were used as positive controls.
As preported previously (Bockamp et al., 1997) , both core promoter 1a and core promoter 1b displayed minimal activity following stable transfection into F4N cells (data not shown). By contrast, 70.2E3 which contained both promoters and the +3HS gave rise to a 88-fold increase in luciferase activity relative to pGL-2 basic ( Figure 5 ). Incorporating the 710HS did not signi®cantly alter the activity of 70.2E3. However, the +7HS and +17/ 18HS both further increased the relative luciferase activity of 70.2E to 225 and 250 respectively, values which were well in excess of those obtained using the positive control plasmid, pA3RSVluc (data not shown). The 77.0E3 construct (containing the 73/ 4HS) displayed reduced activity relative to 70.2E3. These results suggest that the +3HS, +7HS and +7HS and +17/18HS all function as enhancers in erythroid cells after chromatin integration and raises the possibility of a negative regulatory element in the vicinity of the 73/4.5HS.
In M1 cells the two core promoters were again eectively silent following integration in chromatin (Bockamp et al., 1997) whereas the 70.2E3 construct was strongly active and produced a 79-fold increase in luciferase activity over background ( Figure 5 ). This observation suggests that a positive element in the vicinity of the +3HS was functional in M1 cells as well as in F4N cells. Further experiments will be required to determine whether this element is the same as the one active in F4N cells. The 710HS had no eect on the function of 70.2E3, but inclusion of the +17/18HS resulted in a 20-fold fall in activity. Even more striking were the eects of the 73/4.5HS and the +7HS both of which eectively abolished expression from 70.2E3.
Much lower levels of luciferase activity were obtained in BW5147 cells. The 70.2E3 construct produced only background activity. The maximum activity obtained was 35-fold over background, and this was achieved using 77.0E3. The net transcriptional activity of the SCL locus is likely to be the result of positive and negative in¯uences. The activity of the 77.0E3 construct in BW may therefore re¯ect the fact that this construct is lacking negative regulatory elements present in the endogenous SCL locus. Alternatively the endogenous locus may be maintained in an inactive state by its methylation or chromatin structure.
Taken together with the transient transfection data these results identify the key components of a complex interacting network of regulatory elements that control the pattern of SCL expression during haematopoiesis. Four elements are of particular signi®cance. The +17/ 18HS elements acted as a potent erythroid enhancer in transient and stable assays, yet had chromatindependent silencer activity in primitive myeloid cells. The +7HS functioned as a powerful chromatindependent silencer in primitive myeloid cells, but as an enhancer in erythroid cells. The 73/4.5HS displayed chromatin-dependent silencer activity in M1 and F4N cells. The DNA fragment containing the 73/ 4.5HS also exhibited modest enhancer activity in transient assays in both cell types. This may re¯ect the presence of two functionally distinct elements within the DNA fragment. The +3HS functioned as a chromatin-dependent enhancer in M1 cells. In F4N cells, inclusion of the +3HS produced a modest (fourfold) enhancement relative to promoter 1a (Figure 3 ). However in stable assays inclusion of the +3HS produced a 100-fold increase in activity relative to promoter 1a (Figures 5 and 6 ). These data suggest that the integration in chromatin is required for full activity of the +3HS in both M1 and F4N cells. It is interesting to note that the DNA fragments containing the +3HS and +17/18HS functioned as potent regulatory elements in M1 and F4N cells and yet the hypersensitive sites themselves were only detected in F4N . Perhaps the endogenous +3HS and +17,18HS elements are functionally active in M1 cells but have adopted a chromatin structure that is not hypersensitive to DNaseI. Alternatively it is possible that the endogenous +7HS exerts a strong bidirectional silencing activity in M1 cells which shuts down thē anking +3HS and +17,18HS.
The 3' enhancer displayed promoter speci®city
The 70.2E3 construct contained both promoter 1a and promoter 1b, and so the 3' enhancer may have been interacting with one or both SCL promoters. To address the promoter speci®city of the 3' enhancer a further series of constructs were therefore generated containing promoter 1a, promoter 1b, or the SV40 early promoter together with the +17/18HS element. As can be seen from Figure 6a , in transient assays using F4N cells the +17/18HS produced a two-fold increase in the activity of the SV40 promoter but had little or no eect on SCL promoter 1a or 1b. We then considered the possibility that the 3' enhancer might require integration in chromatin for some aspects of its activity. The same constructs were therefore used in a series of stable transfection experiments in F4N cells (Figure 6b ). These revealed a marked enhancing eect of the +17/18HS on the SV40 promoter and on SCL promoter 1a but only a minimal eect on promoter 1b. These results suggest that the +17/18HS element exhibits promoter speci®city and can distinguish between the two SCL promoters.
Discussion
During development SCL expression is essential for the formation and/or survival of pluripotent haematopoietic stem cells (Porcher et al., 1996; Robb et al., 1996) . In adult haematopoiesis SCL is expressed in multipotent progenitors and also in committed erythroid, mast and megakaryocytic cells (Cross et al., 1994; Green et al., 1992; Mouthon et al., 1993; but SCL expression is extinguished during dierentiation along several other lineages (Cross et al., 1994; Tanigawa et al., 1993) . Analysis of the molecular basis for this pattern of expression promises to illuminate the mechanisms controlling the development of haematopoietic stem cells, as well as the commitment of stem cells to individual haematopoietic lineages.
SCL expression is controlled by a complex network of positive and negative lineage-restricted regulatory elements
We have chosen to study the regulation of the murine SCL gene in view of the wealth of murine cellular models for studying haematopoiesis. In this paper we have characterized distant regulatory elements in cell lines representing three haematopoietic cell types: committed erythroid cells which express SCL, CD34 positive primitive myeloid cells which also express SCL and T cells which do not express SCL. Our results demonstrate that the two SCL expressing cell types exhibited overlapping patterns of DNase I hypersensitive sites, with each cell type displaying both unique and shared sites. Furthermore the DNase I hypersensitive sites¯agged the positions of both positive and negative regulatory elements that functioned in a celltype speci®c manner. Four of these elements are of particular interest. The +17/18HS element functioned as a potent erythroid enhancer producing 30-and 70-fold increase over constructs containing promoter 1a and SV40 promoter respectively after stable transfection. Preliminary sequence analysis has demonstrated the presence of several GATA motifs in the region of the +18HS (data not shown) and so this 3' enhancer may prove to be GATA-1 responsive in erythroid cells. M1 cells express GATA-2 (but no GATA-1) yet lack the +17/18HS, and so GATA-2 is clearly not sucient for either the formation or the enhancer activity of the +17/18HS. The 3' enhancer was found to up-regulate SCL promoter 1a but not SCL promoter 1b. Promoter 1a, but not promoter 1b, contains functionally important GATA-1 sites (Aplan et al., 1992; Bockamp et al., 1995; Lecointe et al., 1994) . This may be signi®cant since it has been suggested that interactions between a promoter and its cognate enhancer can be mediated by GATA-1 selfassociation (Crossley et al., 1995) or GATA-1/SP-1 interaction . SCL promoter 1a contains one SP-1 and two GATA-1 sites while the SV40 promoter contains several SP-1 consensus binding sites. As well as acting as an erythroid enhancer, the 5 kb fragment containing the +17/ 18HS also functioned as a silencer in M1 cells. It is not yet clear whether these observations re¯ect the presence of two discrete elements or a single bifunctional element capable of responding dierently to the transcriptional environment present in the two cell types. Silencing elements do not necessarily exhibit nuclease hypersensitivity, especially if they exert their silencing eect by generating an inactive chromatin structure (Zink et al., 1995) , which may explain the absence of DNaseI hypersensitive sites within the +17/18HS in M1 cells.
The characteristics of the +3HS element were very dierent from the 3' enhancer. In transient assays the +3HS was modestly active in F4N cells but was inactive in M1 cells. By contrast it was very active following stable transfection experiments in both of these cell types. Full activity of the +3HS was therefore chromatin dependent and did not require the presence of GATA-1. We have noted before (Begley et al., 1994) that the sequence immediately upstream of exon 3 is highly conserved between the human and murine loci, suggesting the presence of an important regulatory element. The +7HS and 73/4.5HS marked the sites of potent negative regulatory elements which completely abolished the enhancing eect of the +3HS on the SCL promoter region in M1 cells. In addition the +7HS functioned as an enhancer in F4N cells. As with the +17/18HS, it is not clear whether this re¯ects the presence of two separate elements or a single bifunctional element. The presence of silencers functioning in M1 cells but not in F4N cells is consistent with the observation that SCL mRNA levels in M1 cells were several fold lower than those in erythroid cells (Green et al., 1991b) and suggests that down regulation of SCL following commitment to non-expressing lineages is not merely a passive consequence of GATA-1 extinction. The fact that the endogenous SCL gene was transcriptionally active in M1 cells implies that the eect of the silencers is countered by one or more positive elements which remain to be identi®ed.
Our results should be compared with those reported by Leroy-Viard et al., 1994 for the human SCL gene. This group described DNase I hypersensitive sites in human leukaemic T cell lines expressing SCL as a result of chromosome rearrangements and also in human erythroid cell lines (K562 and HEL). No functional data were presented. Hypersensitive sites were identi®ed in K562 and HEL approximately 10 kb, 7 kb and 3 kb upstream of the promoter with another site upstream of exon 3. These sites may well correspond to our 710HS, 73/4.5HS and +3HS. However no site corresponding to our +7HS or +17/ 18HS was detected. These discrepancies may represent species speci®c dierences. Alternatively, they may re¯ect dierences in the cell types being analysed. Murine erythroleukaemia cells are derived by postnatal infection of mice with the Friend retroviral complex, express adult globins and appear to represent an erythropoietin-responsive stage of adult erythroid dierentiation somewhere between the BFU-E and CFU-E (Friend et al., 1971; Marks and Rifkind, 1978) . K562 and HEL cells more closely resemble fetal or embryonic erythroblasts since they express fetal/ embryonic globin and LDH isozyme patterns together with the i antigen (Benz et al., 1980) .
Chromatin dependent regulatory elements
It has become increasingly clear over the past few years that chromatin structure plays a pivotal role in regulating gene transcription (Ernst and Smale, 1995; Felsenfeld, 1992; Lewin, 1994) . Several cis-acting regulatory elements including locus control regions (LCRs) and silencers appear to function by in¯uencing chromatin structure within a region and are frequently dependent upon integration in chromatin for their activity. As a result, two broad classes of enhancers are now recognised. The ®rst of these are the classical enhancers which do not require to be integrated in chromatin for their activity and which therefore function well in transient reporter assays. Activators binding these elements interact directly or indirectly with components of the general transcriptional machinery at the promoter (Kingston and Zawel and Reinberg, 1995) . The second category consists of chromatin-dependent enhancers which exhibit little or no activity in transient assays but function well in stable transfection or transgenic experiments. Examples include the b-globin HS3 and 4 (Fraser et al., 1990; Pruzina et al., 1991; Tuan et al., 1989 ) the 75 kb MyoD enhancer (Tapscott et al., 1992) and the 5' enhancer of the CD34 gene (May and Enver, 1995) . At least some of these elements have been shown to in¯uence chromatin structure. However, the functional distinction between chromatin-dependent and chromatin-independent enhancers is not straightforward. Thus, the b-globin HS2 and metallothionein enhancer can both function well in transient assays but recent evidence also suggests that they suppress the development of repressive chromatin structures (Walters et al., 1996) . Perhaps in these cases the eect on chromatin structure is indirect and secondary to altered transcriptional activity of the locus, whereas chromatin-dependent enhancers directly modulate chromatin structure.
What is the relationship between chromatin-dependent enhancers and LCRs? The concept of an LCR arose out of studies of the b-globin locus. A DNA region spanning 20 kb and containing 4 hypersensitive sites was found to confer tissue speci®c, stage speci®c, position independent and copy-number dependent expression of linked genes (Forrester et al., 1986; Grosveld et al., 1987; Tuan et al., 1985) . These criteria have subsequently been used as the de®ning features of an LCR and more recently the concept of single-copy transgene function has been added (Ellis et al., 1993) . Characterisation of individual b-globin hypersensitive sites has shown that they display dierent functional characteristics and that LCR activity requires at least two separate functions: a chromatin opening activity provided by HS3 and an enhancing function provided by HS2 (Ellis et al., 1996) . Thus, b-globin LCR activity consists of several separable functions provided by distinct elements. This principle is consistent with the proposal that LCR function at the lysozyme locus is provided by the combined action of multiple cis-acting control regions (Bonifer et al., 1994) , and it also accords with the realisation that several chromatindependent enhancers do not, on their own, ful®l the criteria for LCR activity (May and Enver, 1995; Tapscott et al., 1992) . Our data demonstrate the existence of at least three SCL enhancers with constrasting degrees of chromatin dependence. The SCL +3HS displayed little or no activity in transient assays in F4N or M1 cells respectively, but was strongly active following integration in chromatin in both cell lines. By contrast the +7HS and the +17/ 18HS exhibited enhancer activity in both transient and stable assays in F4N cells. We have not formally studied whether individual SCL regulatory elements conform to the current de®nition of an LCR, since our results suggest that varying combinations of regulatory elements serve to direct SCL expression in dierent haematopoietic cell types. We therefore suspect that LCR function is likely to be provided by lineagespeci®c and dierentiation stage-speci®c combinations of the regulatory elements that we have de®ned. Transgenic experiments are underway to address this possibility.
The SCL locus also contained three potent lineagespeci®c and chromatin-dependent silencers in the vicinity of the 73/4.5HS, +7HS and +17/18HS. Silencing was ®rst described in yeast (Brand et al., 1985) , but has subsequently been extensively analysed in¯ies (Bienz and MuÈ ller, 1995; Paro, 1990) . In Drosophila, evidence has been accumulating for two classes of cis-acting negative regulatory elements which respectively initiate or maintain repression. The members of the ®rst category initiate repression early in development, function transiently, act at short range to repress closely linked enhancers or promoters, and bind cell speci®c proteins such as hunchback, Kruppel, even skipped and engrailed (Bienz and MuÈ ller, 1995; Biggin and Tjian, 1989; Jaynes and O'Farrell, 1991) . The second category is more similar to yeast silencers in that its members confer long-term silencing and function over large distances. Yeast silencers were originally de®ned as being position-independent, orientation-independent and capable of repressing heterologous promoters (Brand et al., 1985) . However, it is now apparent that silencers are functionally heterogeneous and that some may be positiondependent (Vacher and Tilghman, 1990) , orientationdependent (Zink and Paro, 1995) or may exhibit promoter-speci®city (Busturia and Bienz, 1993; MuÈ ller, 1995) . The SCL 73/4.5HS, +7HS and +17/18HS resemble yeast silencers and the second category of Drosophila negative regulatory elements since they operated over several kilobases and were chromatindependent. These results suggest that they are likely to function by directly in¯uencing chromatin structure as has been invoked for the regulation of mating type in S.cerevisiae (Braunstein et al., 1993; Hecht et al., 1995; Laurenson and Rine, 1992) and homeotic genes in Drosophila (Bienz and MuÈ ller, 1995; Paro, 1990 ).
Materials and methods

Cell culture
The murine erythroid cell lines F4N and J2E, the murine T-cell line BW5147 and the murine CD34 positive cell line M1 have been described previously (Bockamp et al., 1995) (Ichikawa, 1969) . BW5147 and M1 were cultured in RPMI 1640 plus 10% foetal calf serum and F4N in DMEM plus 10% foetal calf serum.
Analysis of DNase I hypersensitivity
Approximately 3610 8 cells were rinsed in phosphate buered saline (PBS) and resuspended in 20 ml of homogenisation buer (10 mM Tris pH 7.4, 15 mM NaCl, 0.15 mM spermine, 0.5 mM spermidine, 1 mM EDTA, 0.1 mM EGTA, 0.2% NP-40, 5% sucrose). After Dounce homgenisation, the homogenate was spun through a 10% sucrose layer and resuspended in buer (10 mM Tris pH 7.4, 15 mM NaCl, 60 mM KCl, 0.15 mM spermine, 0.5 mM spermidine). After adding DNaseI (Sigma) (0.8 ± 16 mg), samples were incubated at 378C in the presence of 50 mM MgCl 2 and 50 mM CaCl 2 for 10 min. Reactions were stopped by adding 12.5 mM EDTA and 1% SDS and the DNA was isolated following proteinase K digestion/ phenol extraction and ethanol precipitation. After digestion with restriction enzymes, the DNA was analysed by Southern blotting. Probes used were as follows: p1 ± a 220 bp Sau3AI/ApaI fragment 50 bp upstream of exon 1a; p2 ± a 596 bp XmnI/KpnI fragment from exon 6; p3 ± a 1200 bp HindIII fragment 260 bp upstream of the EcoRI site in exon 6; p4 ± an 810 bp KpnI/SacI fragment extending 3' of SCL exon 6.
Preparation of reporter constructs
Luciferase reporter constructs were generated in pGL-2 basic (Promega). SCL genomic DNA contained in the 70.2E3, 77.0E3 and +7HS inserts was subcloned from a l phage Balb/c genomic library (Begley et al., 1994) . The insert in 70.2E3 extended from an EspI site 187 bp upstream of exon 1a to a XcmI site 91 bp into exon 3, the 77.0E3 insert from a KpnI site 7 kb upstream of exon Ia to the same XcmI site in exon 3 and the +7HS insert from a Sau3AI site 1 kb upstream of exon 4 to an NdeI site 75 bp into exon 5. The +17/18HS insert was subcloned from a 129 l ®x genomic library (Stratagene) and extended from a BglII site 670 bp upstream to a Sau3AI site 4.5 kb downstream of the polyA site. The 710HS insert was subcloned from a Pl clone isolated from a C57/B16 genomic library (Zehetner and Lehrach, 1994) and extended from a BglII site at 710 kb to a KpnI site at 77 kb.
Transient transfections
Transient transfections were carried out as described (Bockamp et al., 1995) with the exception that only 6 mg of the pEF-BOS lacZ vector was used for normalisation of each pulse. Also, in order to adjust for the large size dierences between the reporter constructs used in this study, the molar amount of reporter construct added to each pulse was kept constant using 10 mg of pGL-2 basic and proportionally more of the larger constructs. The total amount of DNA added to each pulse was kept constant by adding the required amount of the plasmid pGEM11ZF+ (Promega). Luciferase and b-galactosidase assays were carried out as described (Bockamp et al., 1995) . The relative light units presented are the mean of at least four independent experiments and the results obtained were con®rmed using a second DNA preparation for each construct.
Stable transfections
3610
7 F4N, BW5147 or M1 cells were electroporated (960 mFd, 250 V) with 3 mg of linearised PGK puroPa vector (kindly provided by Dr S Cory) and a tenfold molar excess of the linearised luciferase plasmid. After 24 h, electroporated cells were transferred into selective medium containing 2 mg/ml (F4N and BW5147) or 10 mg/ml (M1) puromycin (Sigma). Cells electroporated with SCL reporter constructs were maintained as 3 independent pools.
Puromycin resistant pools were derived 2 ± 4 weeks following electroporation and luciferase assays were performed using extracts derived from 3610 5 cells for each assay point as described above. For each experiment, assays were performed in duplicate on each pool and a positive control (a pool of cells transfected with pA3RSVluc) and a negative control (a pool of cells transfected with pGL-2 basic) were included in each experiment. This experiment was repeated on three separate occasions for each SCL construct. Results were expressed as fold elevation over the negative control. In addition, this relative luciferase activity was normalised for luciferase DNA content by Southern blot analysis of BamHI and HindIII digested DNA. Filters were probed with a nonrepetitive sequence from the mouse vav gene locus (A Elefanty et al., unpublished results) to normalise DNA loading and with the HindIII/BamHI fragment of the luciferase gene from pGL-2 basic to normalise the luciferase DNA content of test pools to the control pool carrying pGL-2 basic.
